ZEB2 and melanoma: In agreement with the in vitro studies, in the four paired human melanomas where MerTK is overexpressed post-vemurafenib therapy (Figure 1D), nuclear accumulation of Zeb2 is broadly present in resistant tumors (Figure 5G).